OPRX Q4 2023 Earnings — OptimizeRx Corporation Revenue & Financial Results | Market Cap Arena

OPRXOptimizeRx Corporation

$128M

Q4 2023 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$28M+44.3% YoY

Gross Profit

$18M62.9% margin

Operating Income

-$11M-38.4% margin

Net Income

-$4M-14.6% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+73.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$183M

Total Liabilities

$57M

Stockholders' Equity

$127M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$28M	$20M	+44.3%
Gross Profit	$18M	$12M	+43.3%
Operating Income	-$11M	-$864,348	-1161.4%
Net Income	-$4M	-$325,836	-1171.0%